ArticleCancer chemotherapy and pharmacology2023

Clinical results of the EVESOR trial, a multiparameter phase I trial of everolimus and sorafenib combination in solid tumors.

Romain Varnier et al.PubMed ↗Publisher ↗

No numbers read from the abstract.